Federal University of Juiz de Fora   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Juiz de Fora Brazil (1960)

Organization Overview

First Clinical Trial
2011
NCT01619436
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Centro MIneiro de Pesquisa - Juiz de Fora | Federal University of Juiz de Fora | Luiz F. L. Reis, Ph.D. | Santa Casa de Juiz de Fora

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Lung Injury (Phase 3)

Anemia (Phase 4)

Bone Diseases (Phase 4)

Coronavirus Infections (Phase 3)

Crohn Disease (Phase 4)

Fatigue (Phase 4)

Inflammatory Bowel Diseases (Phase 4)

Intestinal Diseases (Phase 4)

Low Back Pain (Phase 3)

Muscle Weakness (Phase 4)

Pneumonia, Viral (Phase 3)

Respiratory Distress Syndrome (Phase 3)

Respiratory Distress Syndrome, Newborn (Phase 3)

Sarcopenia (Phase 4)

Severe Acute Respiratory Syndrome (Phase 3)

Vitamin D Deficiency (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 10